Oxybutynin Chloride Tablet
Product Images NDC 50111-456

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50111-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxybutynin Structural Formula (Image 1)

FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
This is a medication prescription for Oxybutynin with a dosage of 5mg to be taken thrice daily. The rest of the text appears to be a graph or diagram showing the relationship between time and a certain parameter.*
FDA Label Image

Figure 2 Mean Steady-state (Image 3)

FDA Label Image

Label (Image 4)

Label (Image 4)
This is a description of a medication marked with NDC 50111-456-01. The medication is Oxybutynin Chloride, available in the form of USP tablets with 5 mg strength in a pack of 100 tablets. The packaging contains instructions for use and storage, including dosage information and recommended storage temperature. The medication is manufactured in Bulgaria by Balkanpharma Dupnitsa AD and distributed in North Wales, PA, by Teva Pharmaceuticals USA, Inc. The lot and expiration date are provided on the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.